FREQUENCY OF NEURAL TUBE DEFECT(NTD) AND ASSOCIATED ANOMALIES IN WOMEN WITH PERINATAL FOLIC ACID SUPPLEMENTATION PRESENTING TO HAYATABAD MEDICAL COMPLEX, PESHAWAR
DOI:
https://doi.org/10.71000/ann8mp57Keywords:
Anemia, , Diabetes Mellitus, , Folic Acid, Hypertension, Neural Tube Defects, Prenatal Care, Risk FactorsAbstract
Background: Neural tube defects (NTDs) are among the most common and severe congenital anomalies, with spina bifida and anencephaly being the most prevalent. Despite global advancements in prevention through periconceptional folic acid supplementation, NTDs continue to occur, particularly in low-resource settings. In developing countries, limited health education, suboptimal prenatal care, and overlooked maternal comorbidities may contribute to the continued burden of NTDs, even among supplement users.
Objective: To determine the frequency of neural tube defects and associated anomalies in women who reported periconceptional folic acid supplementation and to assess the association of NTDs with maternal and demographic variables.
Methods: A cross-sectional study was conducted at the Department of Obstetrics and Gynecology, Hayatabad Medical Complex, Peshawar, over six months. A total of 385 women aged 15–49 years who reported using folic acid at least one month before conception through two months after were enrolled using non-probability consecutive sampling. Data on demographics, health status, and ultrasound-confirmed NTDs were collected and analyzed using SPSS version 22. Mean and standard deviation were calculated for continuous variables, while frequencies and percentages were reported for categorical variables. Associations were tested using Chi-square and Fisher’s Exact tests with a significance level set at p < 0.05.
Results: The frequency of NTDs was 2.3% (9 out of 385). No statistically significant association was observed between NTDs and maternal age (p=0.081), BMI (p=0.302), gravidity (p=0.350), parity, education level (p=1.000), socioeconomic status (p=0.282), dietary pattern (p=1.000), or cousin marriage (p=1.000). A statistically significant association was found between maternal comorbidities—such as anemia, hypertension, and diabetes—and NTDs (p=0.031).
Conclusion: Folic acid supplementation remains essential in reducing the incidence of NTDs; however, it is not universally protective. Maternal comorbid conditions may significantly increase the risk of NTDs. Preventive efforts must include comprehensive maternal health screening and management, alongside continued promotion of folic acid use.
References
Ssentongo P, Heilbrunn ES, Ssentongo AE, Ssenyonga LVN, Lekoubou A. Birth prevalence of neural tube defects in eastern Africa: a systematic review and meta-analysis. BMC Neurol. 2022;22(1):202.
Mai CT, Evans J, Alverson CJ, Yue X, Flood T, Arnold K, et al. Changes in Spina Bifida Lesion Level after Folic Acid Fortification in the US. J Pediatr. 2022;249:59-66.e1.
Seyoum Tola F. The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA. Medicine (Baltimore). 2024;103(19):e38154.
Aydin S, Jenkins A, Detchou D, Barrie U. Folate fortification for spina bifida: preventing neural tube defects. Neurosurg Rev. 2024;47(1):724.
Wald NJ. Folic acid and neural tube defects: Discovery, debate and the need for policy change. J Med Screen. 2022;29(3):138-46.
Crider KS, Qi YP, Yeung LF, Mai CT, Head Zauche L, Wang A, et al. Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies. Annu Rev Nutr. 2022;42:423-52.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, et al. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Cochrane Database Syst Rev. 2022;2(2022).
Viswanathan M, Urrutia RP, Hudson KN, Middleton JC, Kahwati LC. Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama. 2023;330(5):460-6.
Ferrazzi E, Tiso G, Di Martino D. Folic acid versus 5- methyl tetrahydrofolate supplementation in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020;253:312-9.
Kancherla V, Wagh K, Priyadarshini P, Pachón H, Oakley GP, Jr. A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects. Birth Defects Res. 2022;114(20):1392-403.
Wilson RD, O'Connor DL. Guideline No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid-Sensitive Congenital Anomalies. J Obstet Gynaecol Can. 2022;44(6):707-19.e1.
Rubin G, Stewart C, McGowan L, Woodside JV, Barrett G, Godfrey KM, et al. Maternal folic acid supplementation and the risk of ankyloglossia (tongue-tie) in infants; a systematic review. PLoS One. 2023;18(11):e0294042.
Keuls RA, Finnell RH, Parchem RJ. Maternal metabolism influences neural tube closure. Trends Endocrinol Metab. 2023;34(9):539-53.
Kancherla V. Neural tube defects: a review of global prevalence, causes, and primary prevention. Childs Nerv Syst. 2023;39(7):1703-10.
Kamura S, Sasaki A, Ogawa K, Kato K, Sago H. Periconceptional folic acid intake and disturbing factors: A single-center study in Japan. Congenit Anom (Kyoto). 2022;62(1):42-6.
Zhou Y, Crider KS, Yeung LF, Rose CE, Li Z, Berry RJ, et al. Periconceptional folic acid use prevents both rare and common neural tube defects in China. Birth Defects Res. 2022;114(5-6):184-96.
Abate BB, Kumsa H, Kibret GA, Wodaynew T, Habtie TE, Kassa M, et al. Preconception Folic Acid and Multivitamin Supplementation for the Prevention of Neural Tube Defect: An Umbrella Review of Systematic Review and Meta-analysis. Neuroepidemiology. 2025;59(4):412-25.
Iglesias-Vázquez L, Serrat N, Bedmar C, Pallejà-Millán M, Arija V. Prenatal folic acid supplementation and folate status in early pregnancy: ECLIPSES study. Br J Nutr. 2022;128(10):1938-45.
Kannane S, Touloun O, Boussaa S. The prevalence of neural tube defects and their prevention by folic acid supplementation. Clin Nutr ESPEN. 2024;63:57-67.
Samaniego-Vaesken ML, Morais-Moreno C, Carretero-Krug A, Puga AM, Montero-Bravo AM, Partearroyo T, et al. Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review. Nutrients. 2024;16(18).
Yasmin S, Siddiqa A, Rockliffe L. Knowledge of Neural Tube Defects and Prevention Through Folic Acid Use Among Women in Faisalabad, Punjab, Pakistan: a cross-Sectional Survey. Int J Womens Health. 2022; 14:425-34.
Mai CT, Evans J, Alverson CJ. Changes in Spina Bifida Lesion Level after Folic Acid Fortification in the US. J Pediatr. 2022; 249:59-6.
Dean. Neural tube defects persist after fortification. The editors' perspectives. 2020;226 226;1-4.
Singh N, Mishra R, Misra P. Folate Receptor Alpha is Decreased in Pregnancy Affected with Fetal Neural Tube Defect: A Case Control Study. Neurol India. 2022;70(5):1836-39.
Begashaw B, Tariku Z, Berhane A. Preconception of folic acid supplementation knowledge among Ethiopian women reproductive age group in areas with high burden of neural tube defects: a community based cross-sectional study. J Nutr Sci. 2022 ;11: e48.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Roman Bibi, Ayesha khan, Maimuna Aurangzeb, Ghazala Shams (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
